SCHEMBL5845286

SCHEMBL5845286

O=C(O)CSc1ccc(C(=O)Nc2ccc(F)cc2)cn1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CXCR2 P25025 20/20 1.00
CXCR1 P25024 7/20 0.76

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5845566 0.90 CXCR2 (0.81) CXCR2CXCR1
SCHEMBL5846794 0.89 CXCR2 (0.80) CXCR2CXCR1
SCHEMBL5845414 0.88 CXCR2 (0.78) CXCR2CXCR1
SCHEMBL5845348 0.88 CXCR2 (0.89) CXCR2CXCR1
SCHEMBL5846271 0.86 CXCR2 (1.00) CXCR2CXCR1
SCHEMBL5846781 0.86 CXCR2 (1.00) CXCR2CXCR1
SCHEMBL5847562 0.86 CXCR2 (0.76) CXCR2CXCR1
SCHEMBL3207238 0.86 CXCR2 (0.75) CXCR2CXCR1
SCHEMBL5847566 0.85 CXCR2 (0.74) CXCR2CXCR1
SCHEMBL5659975 0.84 CXCR2 (0.73) CXCR2CXCR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7151112-B1 Pharmaceutical uses and synthesis of nicotinamides UCB SA (GB) 2006-12-19 US disclosed
US-6777432-B1 TREATING A SUBJECT HAVING AN INFLAMMATORY DISORDER ALLEVIATED BY THE INHIBITION OF GRO- ALPHA CYTOKINES DARWIN MOLECULAR CORPORATION 2004-08-17 US disclosed